CBLLNMSHealthcare·Medical Devices#45 in industry

CeriBell, Inc.

Reports in 14d· 2026-05-11

-3.4% · 90d

$21.14

-0.04 (-0.19%)

After-Hours $21.14(+0.00)

News

No News Yet

Press releases and SEC filings for CBLL will appear here as they are published.

Check back later for updates

Key Data

Market Cap$800.6M

Open$21.10

Prev Close$21.18

Day Range$21.05 – $21.59

52W Range$10.85 – $24.33

Volume144,364

P/E (TTM)—

EPS$-1.46

Dividend Yield—

Beta—

Profit Margin-59.97%

Revenue Growth33.70%

Price Target$27.57(+30.4%)

Next Earnings2026-05-11(14d)

Analyst Ratings

Strong Buy8 analysts

Buy 8Hold 0Sell 0

About

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Healthcare · Medical Devices

327 employees

www.ceribell.com